Information  X 
Enter a valid email address

Phorm Corporation (PHRM)

  Print   

Tuesday 28 October, 2014

Phorm Corporation

TR-1: Notification of major interest in shares

RNS Number : 4229V
Phorm Corporation Limited
28 October 2014
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii

Phorm Corporation Limited

 

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights


An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached


An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments


An event changing the breakdown of voting rights


Other (please specify):

  Due to increase in outstanding shares to 687,843,265

ü

 

3. Full name of person(s) subject to the notification obligation: iii

The Capital Group Companies, Inc.

4. Full name of shareholder(s)

(if different from 3.): iv

See Schedule A

5. Date of the transaction and date on which the threshold is crossed or reached: v

14 October 2014

6. Date on which issuer notified:

15 October 2014

7. Threshold(s) that is/are crossed or

reached: vi, vii

Below 4%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary Shares

SG9999009278

26,150,000

26,150,000



26,150,000


3.80%

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date
xiii

Exercise/
Conversion
Period
xiv

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

 

% of voting
rights






 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise
price

Expiration
date
xvii

Exercise/
Conversion
period
xviii

Number of voting
rights instrument
refers to

% of voting rights xix, xx

 






Nominal

Delta

 



 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

 26,150,000

3.80%

 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
xxi

 

See Schedule A

 

Proxy Voting:

10. Name of the proxy holder:


11. Number of voting rights proxy holder will cease to hold:


12. Date on which proxy holder will cease to hold voting rights:


 

13. Additional information:


14. Contact name:

 Christopher Aquino

15. Contact telephone number:

(213) 615-0469

 

Schedule A (as notified)

 

As of 14 October 2014

 

Phorm Corporation Limited

 


Number of Shares

Percent of Outstanding

The Capital Group Companies, Inc. ("CG") holdings

26,150,000

3.80%

Holdings by CG Management Companies and Funds:



● Capital Research and Management Company

26,150,000

3.80%

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLFEFSSAFLSESS

a d v e r t i s e m e n t